Do analysts rate BMY or INDV?

Bloomsbury Publishing currently has a consensus target price of GBX 800, suggesting a potential upside of 22.32%. Given Bloomsbury Publishing's stronger consensus rating and higher possible upside, equities analysts plainly believe Bloomsbury Publishing is more favorable than Indivior. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bloomsbury Publishing 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Indivior 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Does the media favor BMY or INDV?

In the previous week, Bloomsbury Publishing had 2 more articles in the media than Indivior. MarketBeat recorded 3 mentions for Bloomsbury Publishing and 1 mentions for Indivior. Indivior's average media sentiment score of 0.67 beat Bloomsbury Publishing's score of 0.33 indicating that Indivior is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bloomsbury Publishing 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Indivior 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate HCM or BMY?

Bloomsbury Publishing has a consensus target price of GBX 800, suggesting a potential upside of 22.32%. Given Bloomsbury Publishing's stronger consensus rating and higher possible upside, analysts plainly believe Bloomsbury Publishing is more favorable than HUTCHMED. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HUTCHMED 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Bloomsbury Publishing 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00

Do analysts rate SLS or BMY?

Bloomsbury Publishing has a consensus target price of GBX 800, suggesting a potential upside of 22.32%. Given Bloomsbury Publishing's stronger consensus rating and higher possible upside, analysts plainly believe Bloomsbury Publishing is more favorable than Standard Life UK Smaller Companies Trust. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Standard Life UK Smaller Companies Trust 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Bloomsbury Publishing 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00

Do analysts recommend BMY or ERGO?

Bloomsbury Publishing currently has a consensus price target of GBX 800, suggesting a potential upside of 22.32%. Given Bloomsbury Publishing's stronger consensus rating and higher probable upside, equities analysts clearly believe Bloomsbury Publishing is more favorable than Ergomed. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bloomsbury Publishing 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Ergomed 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Bloomsbury Publishing (BMY) Competitors

GBX 654 +5.00 (+0.77%)

As of 11:58 AM Eastern

Compare

BMY vs. INDV, HCM, GRI, SLS, and ERGO

Should you buy Bloomsbury Publishing stock or one of its competitors? MarketBeat compares Bloomsbury Publishing with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Bloomsbury Publishing include Indivior (INDV), HUTCHMED (HCM), Grainger (GRI), Standard Life UK Smaller Companies Trust (SLS), and Ergomed (ERGO). These companies are all part of the "pharmaceutical products" industry.

How does Bloomsbury Publishing compare to Indivior?

Bloomsbury Publishing (LON:BMY) and Indivior (LON:INDV) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

Indivior has a net margin of 14.30% compared to Bloomsbury Publishing's net margin of 8.28%. Bloomsbury Publishing's return on equity of 12.74% beat Indivior's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bloomsbury Publishing	8.28%	12.74%	7.82%
Indivior	14.30%	-41.70%	2.37%

Bloomsbury Publishing has higher earnings, but lower revenue than Indivior. Indivior is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bloomsbury Publishing	£340.70M	1.56	£37.37M	£27.40	23.87
Indivior	£1.40B	1.38	-£2.36M	-£1.21	N/A

42.1% of Bloomsbury Publishing shares are held by institutional investors. Comparatively, 86.0% of Indivior shares are held by institutional investors. 3.5% of Bloomsbury Publishing shares are held by insiders. Comparatively, 3.4% of Indivior shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Bloomsbury Publishing currently has a consensus target price of GBX 800, suggesting a potential upside of 22.32%. Given Bloomsbury Publishing's stronger consensus rating and higher possible upside, equities analysts plainly believe Bloomsbury Publishing is more favorable than Indivior.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bloomsbury Publishing	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Indivior	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Bloomsbury Publishing pays an annual dividend of GBX 15.43 per share and has a dividend yield of 2.4%. Indivior pays an annual dividend of GBX 15 per share and has a dividend yield of 1.2%. Bloomsbury Publishing pays out 56.3% of its earnings in the form of a dividend. Indivior pays out -1,243.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Bloomsbury Publishing has a beta of 0.401, indicating that its share price is 60% less volatile than the broader market. Comparatively, Indivior has a beta of 0.19, indicating that its share price is 81% less volatile than the broader market.

In the previous week, Bloomsbury Publishing had 2 more articles in the media than Indivior. MarketBeat recorded 3 mentions for Bloomsbury Publishing and 1 mentions for Indivior. Indivior's average media sentiment score of 0.67 beat Bloomsbury Publishing's score of 0.33 indicating that Indivior is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bloomsbury Publishing	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Indivior	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Bloomsbury Publishing beats Indivior on 13 of the 18 factors compared between the two stocks.

How does Bloomsbury Publishing compare to HUTCHMED?

HUTCHMED (LON:HCM) and Bloomsbury Publishing (LON:BMY) are both small-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, media sentiment, valuation, profitability and institutional ownership.

Bloomsbury Publishing has lower revenue, but higher earnings than HUTCHMED. HUTCHMED is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HUTCHMED	£548.51M	2.74	-£52.98M	£53.00	3.30
Bloomsbury Publishing	£340.70M	1.56	£37.37M	£27.40	23.87

HUTCHMED has a beta of 0.453, suggesting that its stock price is 55% less volatile than the broader market. Comparatively, Bloomsbury Publishing has a beta of 0.401, suggesting that its stock price is 60% less volatile than the broader market.

20.4% of HUTCHMED shares are held by institutional investors. Comparatively, 42.1% of Bloomsbury Publishing shares are held by institutional investors. 2.8% of HUTCHMED shares are held by insiders. Comparatively, 3.5% of Bloomsbury Publishing shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Bloomsbury Publishing had 3 more articles in the media than HUTCHMED. MarketBeat recorded 3 mentions for Bloomsbury Publishing and 0 mentions for HUTCHMED. Bloomsbury Publishing's average media sentiment score of 0.33 beat HUTCHMED's score of 0.00 indicating that Bloomsbury Publishing is being referred to more favorably in the news media.

Company	Overall Sentiment
HUTCHMED	Neutral
Bloomsbury Publishing	Neutral

HUTCHMED has a net margin of 104.77% compared to Bloomsbury Publishing's net margin of 8.28%. HUTCHMED's return on equity of 41.38% beat Bloomsbury Publishing's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HUTCHMED	104.77%	41.38%	-5.90%
Bloomsbury Publishing	8.28%	12.74%	7.82%

Bloomsbury Publishing has a consensus target price of GBX 800, suggesting a potential upside of 22.32%. Given Bloomsbury Publishing's stronger consensus rating and higher possible upside, analysts plainly believe Bloomsbury Publishing is more favorable than HUTCHMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HUTCHMED	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bloomsbury Publishing	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Bloomsbury Publishing beats HUTCHMED on 10 of the 16 factors compared between the two stocks.

How does Bloomsbury Publishing compare to Grainger?

Grainger (LON:GRI) and Bloomsbury Publishing (LON:BMY) are both small-cap pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

In the previous week, Bloomsbury Publishing had 3 more articles in the media than Grainger. MarketBeat recorded 3 mentions for Bloomsbury Publishing and 0 mentions for Grainger. Bloomsbury Publishing's average media sentiment score of 0.33 beat Grainger's score of -1.00 indicating that Bloomsbury Publishing is being referred to more favorably in the news media.

Company	Overall Sentiment
Grainger	Negative
Bloomsbury Publishing	Neutral

Grainger presently has a consensus price target of GBX 225.60, indicating a potential upside of 48.71%. Bloomsbury Publishing has a consensus price target of GBX 800, indicating a potential upside of 22.32%. Given Grainger's higher possible upside, equities research analysts clearly believe Grainger is more favorable than Bloomsbury Publishing.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Grainger	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
Bloomsbury Publishing	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Grainger pays an annual dividend of GBX 7.86 per share and has a dividend yield of 5.2%. Bloomsbury Publishing pays an annual dividend of GBX 15.43 per share and has a dividend yield of 2.4%. Grainger pays out 28.8% of its earnings in the form of a dividend. Bloomsbury Publishing pays out 56.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Grainger is clearly the better dividend stock, given its higher yield and lower payout ratio.

Grainger has a net margin of 54.91% compared to Bloomsbury Publishing's net margin of 8.28%. Bloomsbury Publishing's return on equity of 12.74% beat Grainger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Grainger	54.91%	6.53%	2.14%
Bloomsbury Publishing	8.28%	12.74%	7.82%

Grainger has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market. Comparatively, Bloomsbury Publishing has a beta of 0.401, suggesting that its stock price is 60% less volatile than the broader market.

Bloomsbury Publishing has higher revenue and earnings than Grainger. Grainger is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Grainger	£238.20M	4.71	-£1.11M	£27.30	5.56
Bloomsbury Publishing	£340.70M	1.56	£37.37M	£27.40	23.87

48.3% of Grainger shares are owned by institutional investors. Comparatively, 42.1% of Bloomsbury Publishing shares are owned by institutional investors. 1.5% of Grainger shares are owned by insiders. Comparatively, 3.5% of Bloomsbury Publishing shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Bloomsbury Publishing beats Grainger on 10 of the 18 factors compared between the two stocks.

How does Bloomsbury Publishing compare to Standard Life UK Smaller Companies Trust?

Standard Life UK Smaller Companies Trust (LON:SLS) and Bloomsbury Publishing (LON:BMY) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

42.1% of Bloomsbury Publishing shares are held by institutional investors. 3.5% of Bloomsbury Publishing shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Bloomsbury Publishing has a net margin of 8.28% compared to Standard Life UK Smaller Companies Trust's net margin of 0.00%. Bloomsbury Publishing's return on equity of 12.74% beat Standard Life UK Smaller Companies Trust's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Standard Life UK Smaller Companies Trust	N/A	N/A	N/A
Bloomsbury Publishing	8.28%	12.74%	7.82%

In the previous week, Bloomsbury Publishing had 3 more articles in the media than Standard Life UK Smaller Companies Trust. MarketBeat recorded 3 mentions for Bloomsbury Publishing and 0 mentions for Standard Life UK Smaller Companies Trust. Bloomsbury Publishing's average media sentiment score of 0.33 beat Standard Life UK Smaller Companies Trust's score of 0.00 indicating that Bloomsbury Publishing is being referred to more favorably in the news media.

Company	Overall Sentiment
Standard Life UK Smaller Companies Trust	Neutral
Bloomsbury Publishing	Neutral

Standard Life UK Smaller Companies Trust pays an annual dividend of GBX 0.08 per share. Bloomsbury Publishing pays an annual dividend of GBX 15.43 per share and has a dividend yield of 2.4%. Standard Life UK Smaller Companies Trust pays out 0.0% of its earnings in the form of a dividend. Bloomsbury Publishing pays out 56.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Standard Life UK Smaller Companies Trust	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bloomsbury Publishing	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Bloomsbury Publishing has higher revenue and earnings than Standard Life UK Smaller Companies Trust. Standard Life UK Smaller Companies Trust is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Standard Life UK Smaller Companies Trust	£222.48M	0.00	N/A	£217.40	N/A
Bloomsbury Publishing	£340.70M	1.56	£37.37M	£27.40	23.87

Summary

Bloomsbury Publishing beats Standard Life UK Smaller Companies Trust on 13 of the 15 factors compared between the two stocks.

How does Bloomsbury Publishing compare to Ergomed?

Bloomsbury Publishing (LON:BMY) and Ergomed (LON:ERGO) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and risk.

In the previous week, Bloomsbury Publishing had 3 more articles in the media than Ergomed. MarketBeat recorded 3 mentions for Bloomsbury Publishing and 0 mentions for Ergomed. Bloomsbury Publishing's average media sentiment score of 0.33 beat Ergomed's score of 0.00 indicating that Bloomsbury Publishing is being referred to more favorably in the media.

Company	Overall Sentiment
Bloomsbury Publishing	Neutral
Ergomed	Neutral

Bloomsbury Publishing has higher revenue and earnings than Ergomed. Ergomed is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bloomsbury Publishing	£340.70M	1.56	£37.37M	£27.40	23.87
Ergomed	£152.09M	0.00	£15M	£0.29	N/A

Bloomsbury Publishing has a beta of 0.401, meaning that its share price is 60% less volatile than the broader market. Comparatively, Ergomed has a beta of 0.79, meaning that its share price is 21% less volatile than the broader market.

42.1% of Bloomsbury Publishing shares are held by institutional investors. Comparatively, 71.1% of Ergomed shares are held by institutional investors. 3.5% of Bloomsbury Publishing shares are held by company insiders. Comparatively, 18.2% of Ergomed shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Ergomed has a net margin of 9.87% compared to Bloomsbury Publishing's net margin of 8.28%. Ergomed's return on equity of 18.08% beat Bloomsbury Publishing's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bloomsbury Publishing	8.28%	12.74%	7.82%
Ergomed	9.87%	18.08%	10.16%

Bloomsbury Publishing currently has a consensus price target of GBX 800, suggesting a potential upside of 22.32%. Given Bloomsbury Publishing's stronger consensus rating and higher probable upside, equities analysts clearly believe Bloomsbury Publishing is more favorable than Ergomed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bloomsbury Publishing	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Ergomed	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Bloomsbury Publishing beats Ergomed on 8 of the 15 factors compared between the two stocks.

Get Bloomsbury Publishing News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BMY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BMY vs. The Competition

Export

Metric	Bloomsbury Publishing	Publishing Industry	Communication Sector	LON Exchange
Market Cap	£532.33M	£1.21B	£3.42B	£2.78B
Dividend Yield	2.48%	9.02%	6.71%	6.13%
P/E Ratio	23.87	50.20	14.30	364.73
Price / Sales	1.56	54.72	116.16	87,561.71
Price / Cash	8.91	15.71	15.83	27.85
Price / Book	2.63	1.14	5.15	7.74
Net Income	£37.37M	£59.19M	£124.16M	£5.88B
7 Day Performance	2.12%	-0.94%	0.53%	6.46%
1 Month Performance	6.89%	-1.96%	1.79%	9.67%
1 Year Performance	25.53%	-9.14%	4.91%	75.31%

Bloomsbury Publishing Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BMY Bloomsbury Publishing	2.7087 of 5 stars	GBX 654 +0.8%	GBX 800 +22.3%	+25.0%	£532.33M	£340.70M	23.87	34,300	Gap Up
INDV Indivior	N/A	GBX 1,238 +1.6%	N/A	+33.9%	£1.93B	£1.40B	N/A	1,000	News Coverage Gap Up High Trading Volume
HCM HUTCHMED	N/A	GBX 178.15 +0.8%	N/A	-13.9%	£1.53B	£548.51M	3.36	1,760	News Coverage Positive News
GRI Grainger	4.6586 of 5 stars	GBX 156.20 -0.4%	GBX 225.60 +44.4%	-29.6%	£1.15B	£238.20M	5.72	372
SLS Standard Life UK Smaller Companies Trust	N/A	N/A	N/A	N/A	£715.41M	£222.48M	3.37	10

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:BMY) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bloomsbury Publishing (BMY) Competitors

BMY vs. INDV, HCM, GRI, SLS, and ERGO

How does Bloomsbury Publishing compare to Indivior?

Summary

How does Bloomsbury Publishing compare to HUTCHMED?

Summary

How does Bloomsbury Publishing compare to Grainger?

Summary

How does Bloomsbury Publishing compare to Standard Life UK Smaller Companies Trust?

Summary

How does Bloomsbury Publishing compare to Ergomed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMY vs. The Competition

Bloomsbury Publishing Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bloomsbury Publishing (BMY) Competitors

BMY vs. INDV, HCM, GRI, SLS, and ERGO

How does Bloomsbury Publishing compare to Indivior?

Is BMY or INDV more profitable?

Which has preferable earnings and valuation, BMY or INDV?

Do insiders & institutionals have more ownership in BMY or INDV?

Do analysts rate BMY or INDV?

Is BMY or INDV a better dividend stock?

Which has more risk and volatility, BMY or INDV?

Does the media favor BMY or INDV?

Summary

How does Bloomsbury Publishing compare to HUTCHMED?

Which has better earnings & valuation, HCM or BMY?

Which has more risk and volatility, HCM or BMY?

Do institutionals and insiders have more ownership in HCM or BMY?

Does the media refer more to HCM or BMY?

Is HCM or BMY more profitable?

Do analysts rate HCM or BMY?

Summary

How does Bloomsbury Publishing compare to Grainger?

Does the media favor GRI or BMY?

Do analysts recommend GRI or BMY?

Is GRI or BMY a better dividend stock?

Is GRI or BMY more profitable?

Which has more volatility & risk, GRI or BMY?

Which has higher valuation and earnings, GRI or BMY?

Do insiders and institutionals have more ownership in GRI or BMY?

Summary

How does Bloomsbury Publishing compare to Standard Life UK Smaller Companies Trust?

Do institutionals and insiders believe in SLS or BMY?

Is SLS or BMY more profitable?

Does the media prefer SLS or BMY?

Is SLS or BMY a better dividend stock?

Do analysts rate SLS or BMY?

Which has better valuation & earnings, SLS or BMY?

Summary

How does Bloomsbury Publishing compare to Ergomed?

Does the media prefer BMY or ERGO?

Which has higher valuation & earnings, BMY or ERGO?

Which has more volatility and risk, BMY or ERGO?

Do institutionals & insiders have more ownership in BMY or ERGO?

Is BMY or ERGO more profitable?

Do analysts recommend BMY or ERGO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMY vs. The Competition

Bloomsbury Publishing Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools